Potassium controls every single heartbeat you have, but it’s the kidneys that control your potassium levels. You could say the kidneys are the gatekeeper to your heart. Kidney care is going through dramatic market disruption. Home dialysis is displacing clinics. And patient care management companies are siphoning off patients. Nevertheless, these patients are still ending […]
Ethanol may be 10% of every gas tank, but the economics of making ethanol have become marginal. VIA Fuels enables ethanol plants to use their existing infrastructure and feedstocks to make much more valuable and versatile drop-in, carbon neutral fuels. Unlike ethanol, VIA Fuels can be blended at higher rates to create renewable fuels for […]
Laguna is developing the first ever targeted cell therapy platform that requires no patient cell engineering, providing the benefits of adoptive targeted cell therapy without any of the complexity, cost, or safety issues associated with extraction and ex vivo manufacturing. Their QUAIL platform activates and expands endogenous 𝛄𝛅 T cells from 1-10 million to 1-2 billion circulating cells. This technology can […]
Pesticides are always a compromise: if you kill the mosquitos, you end up killing the bees too. Pyrone discovered a rare natural compound that controls mosquitos and other pests not by killing them, but by temporarily stunning them. Already fast-tracked by the EPA and being tested by the USDA in Gainesville, Pyrone is now scaling […]
Plant based chicken wings — with a signature crispy skin
Revealing the undetectable through single-shot multi-omics.
Despite a decade of innovation into new eco-friendly textile fibers, none of them work on the huge melt-spun fiber machines that enable low costs. 70% of the fibers used by the apparel industry are made by melt-spinning. The result is that virtually all fiber innovation is hindered by costs 2x to 3x higher than petroleum-based […]
Invest in IndieBio Companies
Companies Raising Now
Every season of the year, a new batch and about one-sixth of our alumni are in raise mode. The companies above are currently raising and would love to talk to interested investors. We can set up those meetings or you can contact the companies directly.
Don’t wait for Demo Day!
We encourage our startups to meet with investors during our programs. We announce our new startups a month into the program, and for the next 100 days we expose them in many ways – from 1:1 meetings, pitch practice days, and investor speed dates. A majority of our startups have soft-pencilled full rounds prior to Demo Day. Let us know if you are interested!
Investing with SOSV
IndieBio / SOSV shares a cap table with over 430 funds for the IndieBio portfolio alone. SOSV’s complete network is far larger. Lets us know if you would like to know more about investing with SOSV in biotech, hard tech and Asia cross-border. We love to meet new VCs.
Backing Life Science Founders
The Genesis Consortium is an alliance of VCs and corporates, founded by IndieBio and Mayfield, committed to human and planetary evoluition.
You are in Good Company
Share a Cap Table
by IndieBio
Corporate Partners
We work with hundreds of global corporates, and their CVCs, and we are open to anyone who has innovation onramps designed to facilitate rapid experimentation. We welcome site visits and will take great care of you. Our top priority is speed, but trust is a prerequisite. Every successful IndieBio alumni has great relationships with corporate partners, be they an investor, a supplier, a manufacturer, or a customer.
What works well:
Master-MTAs, standardized two-ways NDAs, no-rights experiments/trials, pilot projects, CVCs with dry powder, and access to real decision-makers, not just gatekeepers.
What doesn’t work:
Exclusivity without upfronts, multi-level decision making, specialized agreements that take extensive legal review to start work, and in-house champions who don’t have bandwidth for new projects.
